# Combining PET/CT and EBV DNA to Evaluate the Hazard of Progression in the Follow-up of Locally Advanced NPC

> **NCT03601390** · — · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 387 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DEVICE:** PET/CT and EBV DNA

## Key facts

- **NCT ID:** NCT03601390
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2019-12-12
- **Final completion:** 2020-12-12
- **Target enrollment:** 387 (ACTUAL)
- **Last updated:** 2020-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03601390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03601390, "Combining PET/CT and EBV DNA to Evaluate the Hazard of Progression in the Follow-up of Locally Advanced NPC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03601390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*